相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers
Jordi Ponce et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis
Christina N. Cordeiro Mitchell et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2020)
Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
Eleonora Porcu et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2020)
Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial
Jori A. Leijdekkers et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Association of BRCA Mutations and Anti-mullerian Hormone Level in Young Breast Cancer Patients
Kyung-A Son et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation
Vinay Gunnala et al.
FERTILITY AND STERILITY (2019)
BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro
Michael Grynberg et al.
HUMAN REPRODUCTION (2019)
Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes
Volkan Turan et al.
REPRODUCTIVE SCIENCES (2018)
Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
Irit Ben-Aharon et al.
Oncotarget (2018)
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients
M. Lambertini et al.
ANNALS OF ONCOLOGY (2018)
Individualised gonadotropin dose selection usingmarkers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperminjection (IVF/ICSI)
Sarah F. Lensen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Antimullerian hormone levels are lower in BRCA2 mutation carriers
Lauren Johnson et al.
FERTILITY AND STERILITY (2017)
Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
Simone C. Oudshoorn et al.
HUMAN REPRODUCTION (2017)
Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield
Joseph M. Letourneau et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2017)
BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD
I. A. P. Derks-Smeets et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2017)
Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women
Begona Diaz de la Noval
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation
Nam D. Tran et al.
FERTILITY AND STERILITY (2016)
Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
Theodora C. van Tilborg et al.
HUMAN REPRODUCTION (2016)
Anti-Mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
Kelly-Anne Phillips et al.
HUMAN REPRODUCTION (2016)
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?
Theodora C. van Tilborg et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2016)
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk
Sara Giordano et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2016)
BRCA Mutations, DNA Repair Deficiency, and Ovarian Aging
Kutluk Oktay et al.
BIOLOGY OF REPRODUCTION (2015)
BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles
Moran Shapira et al.
FERTILITY AND STERILITY (2015)
BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk
Fabrice Kwiatkowski et al.
PLOS ONE (2015)
A randomized trial comparing time intervals from HCG trigger to intrauterine insemination for cycles utilizing GnRH antagonists
Amir Weiss et al.
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE (2015)
BRCA1 germline mutations may be associated with reduced ovarian reserve
Erica T. Wang et al.
FERTILITY AND STERILITY (2014)
Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2014)
BRCA Mutation Carriers Do Not Have Compromised Ovarian Reserve
Rachel Michaelson-Cohen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Comparison of Age at Natural Menopause in BRCA1/2 Mutation Carriers With a Non-Clinic-Based Sample of Women in Northern California
Wayne T. Lin et al.
CANCER (2013)
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation
Amy Finch et al.
FERTILITY AND STERILITY (2013)
Do BRCA1 and BRCA2 Mutation Carriers Have Earlier Natural Menopause Than Their Noncarrier Relatives? Results From the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer
Ian M. Collins et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Impairment of BRCA1-Related DNA Double-Strand Break Repair Leads to Ovarian Aging in Mice and Humans
Shiny Titus et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Correlation of ovarian reserve tests with histologically determined primordial follicle number
Karl R. Hansen et al.
FERTILITY AND STERILITY (2011)
Anti-Mullerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
S. L. Broer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Impact of BRCA Mutations on Female Fertility and Offspring Sex Ratio
Roxana Moslehi et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2010)
Fertility in women with BRCA mutations: a case-control study
Tuya Pal et al.
FERTILITY AND STERILITY (2010)
The antral follicle count: practical recommendations for better standardization
Frank J. M. Broekmans et al.
FERTILITY AND STERILITY (2010)
Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
Ashok R. Venkitaraman
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Ovarian Aging: Mechanisms and Clinical Consequences
F. J. Broekmans et al.
ENDOCRINE REVIEWS (2009)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A. C. Antoniou et al.
BRITISH JOURNAL OF CANCER (2008)
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
A. La Marca et al.
HUMAN REPRODUCTION (2007)
A systematic review of tests predicting ovarian reserve and IVF outcome
F. J. Broekmans et al.
HUMAN REPRODUCTION UPDATE (2006)
Premature menopause in patients with BRCA1 gene mutation
Izabella Rzepka-Gorska et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
E Friedman et al.
BREAST CANCER RESEARCH (2006)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Offspring gender ratio and the rate of recurrent spontaneous miscarriages in Jewish women at high risk for breast/ovarian cancer
I Gal et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
The variability of female reproductive ageing
ERT Velde et al.
HUMAN REPRODUCTION UPDATE (2002)
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
PL Welcsh et al.
HUMAN MOLECULAR GENETICS (2001)
Role of BRCA2 in control of the RAD51 recombination and DNA repair protein
AA Davies et al.
MOLECULAR CELL (2001)
分享论文
